END OF YEAR OPTOMETRIST EDUCATIONAL EVENT
Date: 30/11/2022 (AEDT)
Venue: The Boathouse Shelly Beach, 1 Marine Parade, Manly, NSW, 2095
Provider: Northern Beaches Cataract
Contact: Aymee Loftus, [E] aymeeloftus@northernbeachescataract.com.au, [P] 02 9981 2033
Learning Objectives
- To understand what the preserflo microshunt is
- To understand who it is indicated for
- To understand complications associated with this procedure
- To understand the difference between lacrimation and epiphora
- To explain sites of lacrimal outflow obstruction
- To assess simple office tests of epiphora
- To understand which patients with glaucoma require emergency referral
- To understand which patients with glaucoma require Cat 1 referral (<30 days)
- To understand which patients with glaucoma require Cat 2 referral (<90 days)
- Review of new injection patients and outcomes achieved in 2022
- Review of current limitations in anti-VEGF medication
- Use of gas ??????? in neovascular AMD
- A review of vabysmo antiVEGF
- Understand the indications for strabismus surgery
- Understanding of the basic steps involved in the operation
- Recognition of the importance of restoring ocular alignment
- To look at the rare causes of outer retinal holes
- To discuss the features of hypertensive retinopathy
- To discuss the retinal imaging findings in syphilitic chorioretinitis
- To identify diagnostic features of lamellar holes
- Understand the pathogenesis of lamellar holes
- To discuss management of lamellar holes
Max CPD hours awarded: 4.5
Session Information
| Name |
|---|
| Preserflo Microshunt |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |
| Name |
|---|
| Oculoplastics |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |
| Name |
|---|
| New NSW Glaucoma Referral Guidelines |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |
| Name |
|---|
| Outcomes for Anti-VEGF Patients |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |
| Name |
|---|
| Understanding Strabismus Surgery |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |
| Name |
|---|
| Whodunnit Cases of 2022 |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |
Management of Lamellar Holes
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.5